In June, the Centers for Disease Control issued new guidelines about the vaccination for a variety of conditions, among them the pneumococcal vaccine.
In short, the Advisory Committee on Immunization Practices (ACIP), recommended that adults 65 or older get PCV 13 if they had not been vaccinated before and are not immunocompromised before getting a dose of pneumococcal vaccine polyvalent later on.
The new recommendation has raised questions with both patients and clinicians.
To address some of those questions, Dr. William Schaffner, an infectious disease expert at Vanderbilty University Medical Center and professor of Health Policy, helped explain some of the details in MD Magazine. Schaffner is a member of ACIP, and represents National Foundation for Infectious Diseases (NFID).